Analyst Consensus ?
ConsensusHold36 ratings
Bullish1541.7%
Neutral1747.2%
Bearish411.1%
FN2 Earnings Intelligence
CME Group Inc. analyst ratings
CME Group Inc. (CME) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$298.07Current
$151Low
$262.29Average
$367High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 22, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 22, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 22, 2026 |
| JP Morgan | Overweight | Underweight | Upgrade | Oct 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 22, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 5, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Aug 19, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 23, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 2, 2026 |
| Keefe, Bruyette & Woods | Outperform | Market Perform | Upgrade | Jun 18, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Jun 11, 2026 |
| Erste Group | Hold | Buy | Downgrade | Jun 5, 2026 |
| Argus Research | Hold | Buy | Downgrade | Mar 4, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 5, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Sep 25, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 24, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Oct 8, 2024 |
| Goldman Sachs | Sell | Sell | Maintain | Oct 3, 2024 |
| Rosenblatt | Sell | Sell | Maintain | Apr 25, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 9, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jun 10, 2022 |
| CFRA | Hold | Hold | Maintain | Apr 29, 2020 |
| Berenberg | Hold | Buy | Downgrade | Sep 19, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jan 11, 2019 |
| Jefferies | Buy | Buy | Maintain | Jul 17, 2017 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 29, 2016 |
| CLSA | Underperform | Underperform | Maintain | Jul 14, 2016 |
| Evercore ISI Group | Buy | Hold | Upgrade | May 8, 2015 |
| Compass Point | Neutral | Neutral | Maintain | Oct 21, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jun 14, 2013 |
| Macquarie | Neutral | Outperform | Downgrade | May 21, 2013 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Oct 26, 2012 |
| BGB Securities | Hold | Hold | Maintain | Oct 26, 2012 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Oct 8, 2012 |
| Stifel | Hold | Buy | Downgrade | Oct 8, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $298.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $330 | $295.79 | +10.7% | Oct 22, 2026 |
| Wells Fargo | Daniel Welden | $333 | $295.79 | +11.7% | Oct 22, 2026 |
| Morgan Stanley | Michael Cyprys | $359 | $295.79 | +20.4% | Oct 22, 2026 |
| CLSA | Analyst unavailable | $367 | $295.79 | +23.1% | Oct 22, 2026 |
| Barclays | Benjamin Budish | $321 | $295.79 | +7.7% | Oct 22, 2026 |
| Wells Fargo | Daniel Welden | $315 | $278.03 | +5.7% | Oct 14, 2026 |
| Morgan Stanley | Analyst unavailable | $337 | $276.44 | +13.1% | Oct 9, 2026 |
| Barclays | Analyst unavailable | $281 | $270.18 | -5.7% | Oct 7, 2026 |
| UBS | Alex Kramm | $270 | $263.14 | -9.4% | Oct 5, 2026 |
| Wells Fargo | Daniel Welden | $301 | $265.1 | +1.0% | Oct 1, 2026 |
| Deutsche Bank | Analyst unavailable | $270 | $271.54 | -9.4% | Aug 19, 2026 |
| Morgan Stanley | Michael Cyprys | $330 | $252.8 | +10.7% | Jul 23, 2026 |
| Piper Sandler | Analyst unavailable | $295 | $243.61 | -1.0% | Jul 15, 2026 |
| Morgan Stanley | Analyst unavailable | $324 | $237.46 | +8.7% | Jul 10, 2026 |
| UBS | Alex Kramm | $260 | $236.6 | -12.8% | Jul 6, 2026 |
| Piper Sandler | Patrick Moley | $320 | $248.12 | +7.4% | Jun 17, 2026 |
| Piper Sandler | Patrick Moley | $329 | $267.85 | +10.4% | Jun 15, 2026 |
| Redburn Partners | Analyst unavailable | $323 | $263.8 | +8.4% | Jun 11, 2026 |
| Morgan Stanley | Michael Cyprys | $353 | $282.44 | +18.4% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $316 | $285.71 | +6.0% | Apr 23, 2026 |
| Morgan Stanley | Analyst unavailable | $362 | $294.82 | +21.4% | Apr 10, 2026 |
| UBS | Analyst unavailable | $310 | $297.38 | +4.0% | Feb 6, 2026 |
| RBC Capital | Ashish Sabadra | $302 | $300.42 | +1.3% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $340 | $294.62 | +14.1% | Feb 5, 2026 |
| Barclays | Benjamin Budish | $312 | $294.62 | +4.7% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $319 | $273.41 | +7.0% | Jan 15, 2026 |
| Morgan Stanley | Michael Cyprys | $320 | $269.09 | +7.4% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $304 | $272.42 | +2.0% | Dec 12, 2025 |
| Morgan Stanley | Michael Cyprys | $314 | $269.5 | +5.3% | Oct 23, 2025 |
| UBS | Alex Kramm | $280 | $267.81 | -6.1% | Oct 23, 2025 |
| Deutsche Bank | Analyst unavailable | $300 | $269.59 | +0.6% | Oct 23, 2025 |
| Raymond James | Patrick O'Shaughnessy | $307 | $271.45 | +3.0% | Oct 13, 2025 |
| Barclays | Analyst unavailable | $280 | $263.6 | -6.1% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $312 | $264.46 | +4.7% | Oct 1, 2025 |
| UBS | Alex Kramm | $285 | $261.78 | -4.4% | Sep 8, 2025 |
| Barclays | Benjamin Budish | $298 | $277.18 | -0.0% | Jul 24, 2025 |
| Raymond James | Patrick O'Shaughnessy | $287 | $254.57 | -3.7% | Mar 10, 2025 |
| Oppenheimer | Owen Lau | $258 | $227.43 | -13.4% | Oct 24, 2024 |
| Barclays | Benjamin Budish | $231 | $227.14 | -22.5% | Oct 24, 2024 |
| Citigroup | Christopher Allen | $250 | $223.57 | -16.1% | Oct 3, 2024 |
| RBC Capital | Ashish Sabadra | $235 | $218.47 | -21.2% | Sep 26, 2024 |
| Bank of America Securities | Craig Siegenthaler | $177 | $215.74 | -40.6% | Sep 3, 2024 |
| Deutsche Bank | Brian Bedell | $193 | $198.92 | -35.3% | Jul 25, 2024 |
| Piper Sandler | Patrick Moley | $225 | $199.38 | -24.5% | Jul 25, 2024 |
| Barclays | Benjamin Budish | $209 | $197.25 | -29.9% | Jul 25, 2024 |
| UBS | Alex Kromm | $250 | $203.78 | -16.1% | Jun 5, 2024 |
| Rosenblatt Securities | Andrew Bond | $187 | $212.59 | -37.3% | Apr 25, 2024 |
| Barclays | Benjamin Budish | $228 | $212.59 | -23.5% | Apr 25, 2024 |
| Deutsche Bank | Brian Bedell | $210 | $212.21 | -29.5% | Apr 5, 2024 |
| Credit Suisse | Analyst unavailable | $198 | $174.76 | -33.6% | Feb 7, 2023 |
| Morgan Stanley | Analyst unavailable | $196 | $176.93 | -34.2% | Jan 11, 2023 |
| Piper Sandler | Analyst unavailable | $250 | $171.12 | -16.1% | Dec 19, 2022 |
| Credit Suisse | Analyst unavailable | $210 | $194.69 | -29.5% | Sep 6, 2022 |
| Rosenblatt Securities | Analyst unavailable | $171 | $205.46 | -42.6% | Aug 17, 2022 |
| Deutsche Bank | Analyst unavailable | $212 | $202.14 | -28.9% | Aug 12, 2022 |
| Credit Suisse | Analyst unavailable | $216 | $198.24 | -27.5% | Aug 3, 2022 |
| UBS | Analyst unavailable | $240 | $195.34 | -19.5% | Aug 2, 2022 |
| Morgan Stanley | Analyst unavailable | $226 | $198.5 | -24.2% | Jul 28, 2022 |
| Credit Suisse | Analyst unavailable | $218 | $195.99 | -26.9% | Jul 28, 2022 |
| Morgan Stanley | Analyst unavailable | $242 | $201.51 | -18.8% | Jul 19, 2022 |
| Deutsche Bank | Analyst unavailable | $213 | $203.55 | -28.5% | Jul 13, 2022 |
| Credit Suisse | Analyst unavailable | $233 | $204.36 | -21.8% | Jul 6, 2022 |
| UBS | Analyst unavailable | $246 | $204.36 | -17.5% | Jul 6, 2022 |
| Raymond James | Analyst unavailable | $235 | $204.36 | -21.2% | Jul 6, 2022 |
| Atlantic Equities | Simon Clinch | $235 | $200.43 | -21.2% | Jun 10, 2022 |
| UBS | Analyst unavailable | $258 | $204.68 | -13.4% | Jun 3, 2022 |
| Deutsche Bank | Analyst unavailable | $210 | $190.15 | -29.5% | May 19, 2022 |
| Argus Research | Stephen Biggar | $230 | $200.1 | -22.8% | May 16, 2022 |
| Citigroup | Analyst unavailable | $280 | $223 | -6.1% | Apr 28, 2022 |
| Credit Suisse | Analyst unavailable | $259 | $223.03 | -13.1% | Apr 28, 2022 |
| Raymond James | Analyst unavailable | $254 | $225.93 | -14.8% | Apr 28, 2022 |
| UBS | Alex Kromm | $269 | $237.46 | -9.8% | Apr 5, 2022 |
| Jefferies | Daniel Fannon | $258 | $221.8 | -13.4% | Jan 10, 2022 |
| Berenberg Bank | Eoin Mullany | $190 | $215.65 | -36.3% | Nov 2, 2021 |
| Piper Sandler | Richard Repetto | $230 | $192.18 | -22.8% | Oct 1, 2021 |
| Loop Capital Markets | Kenneth Hill | $151 | $197.42 | -49.3% | Apr 29, 2021 |
| Goldman Sachs | Alexander Blostein | $208 | $194.79 | -30.2% | Apr 28, 2021 |
Track every rating change on CME the moment it posts. Free to start.
Start freeGet the CME recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.